A systematic overview of radiation therapy effects in urinary bladder cancer

Acta Oncologica

Volumn 42, Issue 5-6, 2003, Pages 567-581

  Widmark, Anders ^a   Flodgren, Per ^b   Damber, Jan Erik ^c   Hellsten, Sverker ^b   Cavallin Ståhl, Eva ^b  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOTHERAPY; DRUG DOSAGE; HYPERBARIC CHAMBERS; OXYGEN; SURGERY; TUMORS;

URINARY BLADDER;

RADIOTHERAPY;

CISPLATIN; MISONIDAZOLE;

BLADDER CARCINOMA; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CYSTECTOMY; HUMAN; HYPERBARIC OXYGEN; HYPERTHERMIA; INTERMETHOD COMPARISON; META ANALYSIS; MULTIMODALITY CANCER THERAPY; PHOTOTHERAPY; PREOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; REVIEW; SURVIVAL RATE; TREATMENT INDICATION;

ADULT; AGED; BRACHYTHERAPY; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; SURVIVAL ANALYSIS; SWEDEN; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 0141636525     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841860310014408     Document Type: Review

References (51)

1. Bergkvist A, Ljungqvist A, Moberger G. Classification of bladder tumours based on the cellular pattern. Preliminary report of a clinical-pathological study of 300 cases with a minimum follow-up of eight years. Acta Chir Scand 1965; 130: 371-8.
2. Fossa SD, Ous S, Berner A. Clinical significance of the 'palpable mass' in patients with muscle-infiltrating bladder cancer undergoing cystectomy after pre-operative radiotherapy. Br J Urol 1991; 67: 54-60.
3. Duncan W. Quilty PM. The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage x-ray therapy. Radiother Oncol 1986; 7: 299-310.
4. Pollack A, Zagars GK, Swanson DA. Muscle-invasive bladder cancer treated with external beam radiotherapy: prognostic factors. Int J Radiat Oncol Biol Phys 1994; 30: 267-77.
5. Nilsson S, Ragnhammar P, Glimelius B, et al. A systematic overview of chemotherapy effects in urothelial bladder cancer. Acta Oncol 2001; 40: 371-90.
6. Finney R. The treatment of carcinoma of the bladder by external irradiation. A clinical trial. II. Clin Radiol 1971; 22: 225-9. (C3)
7. Quilty PM, Duncan W, Kerr GR. Results of a randomised study to evaluate influence of dose on morbidity in radiotherapy for bladder cancer. Clin Radiol 1985; 36: 615-8. (C3)
8. Finney R. Treatment of carcinoma of the bladder by external irradiation - a clinical trial part III. Clin Radiol 1980; 31: 423-5. (C3)
9. Turesson I, Carlsson J, Brahme A, et al, and the Swedish Cancer Society Investigation Group. Biological response to radiation therapy. Acta Oncol 2003; 42: 92-106.
10. Edsmyr F, Andersson L, Esposti PL, et al. Irradiation therapy with multiple small fractions per day in urinary bladder cancer. Radiother Oncol 1985; 4: 197-203. (C2)
11. Goldobenko GV, Matveev BP, Shipilov VI, et al. Radiation treatment of bladder cancer using different fractionation regimens. Med Radiol (Mosk) 1991; 36: 14-6. (C2)
12. Naslund I, Nilsson B, Littbrand B. Hyperfractionated radiotherapy of bladder cancer. A ten-year follow-up of a randomized clinical trial. Acta Oncol 1994; 33: 397-402. (C2)
13. Cox JD, Guse C, Asbell S, et al. Tolerance of pelvic normal tissues to hyperfractionated radiation therapy: results of Protocol 83-08 of the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1988; 15: 1331-6. (C3)
14. Fowler J. Biological factors influencing optimum fractionation in radiation therapy. Acta Oncol 2001; 40: 712-7.
15. Maciejewski B, Majewski S. Dose fractionation and tumour repopulation in radiotherapy for bladder cancer. Radiother Oncol 1991; 21: 163-70.
16. Marcial VA, Amato DA, Brady LW, et al. Split-course radiotherapy of carcinoma of the urinary bladder stages C and D1. A radiation therapy oncology group study. Am J Clin Oncol 1985; 8: 185-99. (C2)
17. Kob D, Kloetzer KH, Kriester A, et al. Results of radiotherapeutic optimization within the scope of combined operative-radiologic therapy of urinary bladder cancer. Z Urol Nephrol 1985; 78: 545-50. (C3)
18. Holsti LR. Clinical experience with split-course radiotherapy. A randomized clinical trial. Radiology 1969; 92: 591-6. (C3)
19. Turesson I, Johansson K-A, Mattsson M. The potential of proton and light ion beams in radiotherapy. Acta Oncol 2003; 42: 107-14.
20. Duncan W, Williams JR, Kerr GR, et al. An analysis of the radiation related morbidity observed in a randomized trial of neutron therapy for bladder cancer. Int J Radiat Oncol Biol Phys 1986; 12: 2085-92. (C2)
21. Pointon RS, Read G, Greene D. A randomised comparison of photons and 15 MeV neutrons for the treatment of carcinoma of the bladder. Br J Radiol 1985; 58: 219-24. (C2)
22. Battermann JJ. Results of d+T fast neutron irradiation on advanced tumors of bladder and rectum. Int J Radiat Oncol Biol Phys 1982; 8: 2159-64. (C3)
23. Errington RD, Ashby D, Gore SM, et al. High energy neutron treatment for pelvic cancers: study stopped because of increased mortality. Br Med J 1991; 302: 1045-51. (C3)
24. Duchesne GM, Bolger JJ, Griffiths GO, et al. A randomized trial of hypofractionated schedules of palliative radiotherapy in the management of bladder carcinoma: results of medical research council trial BA09. Int J Radiat Oncol Biol Phys 2000; 47: 379-88. (C1)
25. Zackrisson B, Kjellén E, Glimelius B, et al. and the Swedish Cancer Society Investigation Group. Sensitising and protective substances in radiotherapy and predictive assays. Acta Oncol 2002; 41: 615-22.
26. Cade IS, McEwen JB, Dische S, et al. Hyperbaric oxygen and radiotherapy: a Medical Research Council trial in carcinoma of the bladder. Br J Radiol 1978; 51: 876-8. (C1)
27. Plenk HP. Hyperbaric radiation therapy. Preliminary results of a randomized study of cancer of the urinary bladder and review of the 'oxygen experience'. Am J Roentgenol Radium Ther Nucl Med 1972; 114: 152-7. (C3)
28. Dische S. The hyperbaric oxygen chamber in the radiotherapy of carcinoma of the bladder. Br J Radiol 1973; 46: 13-7. (C3)
29. van der Zee J, Gonzalez Gonzalez D, van Rhoon GC, et al. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 2000; 355: 1119-25. (C3)
30. Abratt RP, Craighead P, Reddi VB, et al. A prospective randomised trial of radiation with or without oral and intravesical misonidazole for bladder cancer. Br J Cancer 1991; 64: 968-70. (C3)
31. Bydder PV, Burry AF, Gowland S, et al. A controlled trial of misonidazole in the curative treatment of infiltrating bladder cancer. Australas Radiol 1989; 33: 8-14. (C3)
32. Papavasiliou C, Yiogarakis D, Davillas N, et al. Treatment of bladder carcinoma with irradiation combined with misonidazole. Int J Radiat Oncol Biol Phys 1983; 9: 1631-3. (C3)
33. Smith JA, Jr, Crawford ED, Paradelo JC, et al. Treatment of advanced bladder cancer with combined preoperative irradiation and radical cystectomy versus radical cystectomy alone: a phase III intergroup study. J Urol 1997; 157: 805-7; discussion 807-8. (C2)
34. Anderstrom C, Johansson S, Nilsson S, et al. A prospective randomized study of preoperative irradiation with cystectomy or cystectomy alone for invasive bladder carcinoma. Eur Urol 1983; 9: 142-7. (C3)
35. Blackard CE, Byar DP. Results of a clinical trial of surgery and radiation in stages II and 3 carcinoma of the bladder. J Urol 1972; 108: 875-8. (C3)
36. Slack NH, Bross ID, Prout GR, Jr. Five-year follow-up results of a collaborative study of therapies for carcinoma of the bladder. J Surg Oncol 1977; 9: 393-405. (C3)
37. Sell A, Jakobsen A, Nerstrom B, et al. Treatment of advanced bladder cancer category T2 T3 and T4a. A randomized multicenter study of preoperative irradiation and cystectomy versus radical irradiation and early salvage cystectomy for residual tumor. DAVECA protocol 8201. Danish Vesical Cancer Group. Scand J Urol Nephrol 1991; (Suppl 138): 193-201. (C2)
38. Bloom HJ, Hendry WF, Wallace DM, et al. Treatment of T3 bladder cancer: controlled trial of pre-operative radiotherapy and radical cystectomy versus radical radiotherapy. Br J Urol 1982; 54: 136-51. (C2)
39. Miller LS. Bladder cancer: superiority of preoperative irradiation and cystectomy in clinical stages B2 and C. Cancer 1977; 39: 973-80. (C3)
40. Mommsen S, Jakobsen A, Sell A. Quality of life in patients with advanced bladder cancer. A randomized study comparing cystectomy and irradiation - the Danish Bladder Cancer Study Group (DAVECA protocol 8201). Scand J Urol Nephrol 1989; (Suppl 125): 115-20. (C2)
41. Horwich A. Commentary 1. In: Hall RR. Clinical management of bladder cancer. London: Loppencott-Raven; 1999. p. 236-8. (C2)
42. Shelley M, Barber J, Mason M. Surgery versus radiotherapy for muscle invasive bladder cancer (Cochrane Review). In: The Cochrane Library. Issue 2: 2003. Oxford: Update Software. (M1)
43. Tait DM, Nahum AE, Rigby L, et al. Conformal radiotherapy of the pelvis: assessment of acute toxicity. Radiother Oncol 1993; 29: 117-26. (C3)
44. Sanchiz F, Milla A, Artola N, et al. Prevention of radioinduced cystitis by orgotein: a randomized study. Anticancer Res 1996; 16: 2025-8. (C2)
45. Nielsen OS, Overgaard J, Overgaard M, et al. Orgotein in radiation treatment of bladder cancer. A report on allergic reactions and lack of radioprotective effect. Acta Oncol 1987; 26: 101-4. (C3)
46. Coppin CM, Gospodarowicz MK, James K, et al. Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 1996; 14: 2901-7. (C3)
47. Blomgren H, Esposti PL, Naslund I, et al. Adjuvant bestatin (Ubenimex) treatment following full-dose local irradiation for bladder carcinoma. Acta Oncol 1990; 29: 809-12. (C2)
48. Stuschke M, Thames HD. Hyperfractionated radiotherapy of human tumors: overview of the randomized clinical trials. Int J Radiat Oncol Biol Phys 1997; 37: 259-67. (M2)
49. Duncan W, Arnott SJ, Jack WJ, et al. A report of a randomized trial of d(15)+Be neutrons compared with megavoltage x- ray therapy of bladder cancer. Int J Radiat Oncol Biol Phys 1985; 11: 2043-9. (C2)
50. Huncharek M, Muscat J, Geschwind JF. Planned preoperative radiation therapy in muscle invasive bladder cancer; results of a meta-analysis. Anticancer Res 1998; 18: 1931-4. (M3)
51. Wallace DM, Bloom HJ. The management of deeply infiltrating (T3) bladder carcinoma: controlled trial of radical radiotherapy versus preoperative radiotherapy and radical cystectomy (first report). Br J Urol 1976; 48: 587-94. (C2)